Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Effect of phosphocreatine on patients treated by medical emergency teams

Official title: The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients: a Randomized Clinical Trial Protocol

Run by Università Vita-Salute San Raffaele · NCT06503016 · Data updated 2026-11-12

This study tests if giving phosphocreatine to hospitalized patients with serious conditions can help them recover faster and shorten their hospital stays compared to those who receive a placebo.

More Cardiac Arrest trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorUniversità Vita-Salute San Raffaele
Academic / other
Locations1 site (Milan)
StatusRecruiting
StartedOctober 8, 2024
Main results expectedApril 2026
Study endsJuly 2026
Registry record updatedAugust 6, 2025
Trial IDNCT06503016 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are hospitalized patients aged 18 and older with impending cardiac failure or other acute conditions requiring MET intervention.

Probably not a fit

Patients currently in the ICU or those with severe renal impairment or other critical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the impact of phosphocreatine (PCr) on hospitalized patients who experience critical conditions requiring intervention from medical emergency teams. It is a multi-center, randomized, placebo-controlled phase 3 trial aimed at confirming the beneficial effects of PCr in reducing hospital stays and improving patient outcomes. The study focuses on patients with impending cardiac failure or other acute conditions that trigger MET activation. By comparing the outcomes of patients receiving PCr versus a placebo, the trial seeks to establish the efficacy of this natural energy-buffering molecule in enhancing recovery.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce hospital stays and improve survival rates for patients experiencing acute medical emergencies.

How similar studies have gone: Previous studies have indicated promising results for phosphocreatine in acute cardiac conditions, suggesting potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Admitted in hospital (but outside ICU)
2. Age\>=18 years
3. Written informed consent
4. Serum creatinine \<=2 mg/dl
5. Patient with impending or underlying cardiac failure or cardiac arrest, irrespectively of the primitive organ failure, and the Medical Emergency Team (MET) is called upon at least one of the following:

   1. Threatened airways;
   2. Respiratory arrest;
   3. Respiratory rate \<5 or \>36 breaths per min;
   4. Pulse rate \<40 or \>140 beats per min;
   5. Systolic blood pressure \< 90 mm Hg;
   6. Sudden fall in level of consciousness;
   7. Fall in Glasgow coma scale of \> 2 points.

Exclusion Criteria:

1. Age \< 18 years;
2. Ongoing cardiac massage;
3. Current hospital admission from a care nursing facility;
4. Planned discharge to a care nursing facility;
5. Reasons for withdrawal of life-sustaining therapy;
6. History of kidney transplantation;
7. Solitary kidney (by any reason);
8. Serum Creatinine \> 2 mg/dl;
9. Immediate need for ICU admission;
10. Known allergy to PCr;
11. Pregnancy;
12. Previous enrollment and randomization into this trial;
13. Administration of PCr in the previous 30 day.

Where it's running

  • IRCCS San Raffaele Scientific Institute
    Milan, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.